Background
==========

Protoporphyrin IX (PPIX) was shown to strongly activate *in vitro* the soluble guanylate cyclase enzyme (sGC), which makes it an interesting drug candidate for treatment of hypertension \[[@B1],[@B2]\]. In order to overcome the problem of PPIX poor bioavailability (especially in the case of oral administration), we decided to exploit the specific uptake pathway of vitamin B~12~, which was frequently used for delivering biologically active substances from the digestive system into the body cells. To this end, we embarked on the synthesis of a series of hybrid molecules, containing PPIX and vitamin B~12~ moieties, linked *via* chains of different length and chemical character \[[@B3]\].

Methods and results
===================

Our synthetic approach is based on the synthesis of linking molecules containing a primary -NH~2~ group and -N~3~ or alkyne group at the other end. Amine functionality allows us to connect these linkers to vitamin B~12~, and to PPIX, finally, the union of the two parts is possible using Cu-catalyzed azide alkyne cycloaddition (the "click reaction") \[[@B4]\].
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